Elevation Point Wealth Partners LLC Increases Stock Holdings in CVS Health Corporation $CVS

Elevation Point Wealth Partners LLC increased its position in shares of CVS Health Corporation (NYSE:CVS) by 2,155.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,548 shares of the pharmacy operator’s stock after purchasing an additional 16,770 shares during the period. Elevation Point Wealth Partners LLC’s holdings in CVS Health were worth $1,323,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. SOA Wealth Advisors LLC. raised its position in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 131 shares during the period. Alteri Wealth LLC grew its position in CVS Health by 3.2% in the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock worth $316,000 after acquiring an additional 131 shares during the period. Holistic Financial Partners increased its stake in CVS Health by 4.1% during the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock worth $256,000 after acquiring an additional 133 shares during the last quarter. Symmetry Partners LLC raised its position in CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after purchasing an additional 141 shares during the period. Finally, Harbor Capital Advisors Inc. lifted its stake in shares of CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

NYSE CVS opened at $75.81 on Tuesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The company has a market cap of $96.45 billion, a P/E ratio of 54.94, a P/E/G ratio of 0.79 and a beta of 0.49. The stock has a 50-day moving average of $78.08 and a two-hundred day moving average of $77.85. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s dividend payout ratio is currently 192.75%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Bank of America cut their price objective on CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Sanford C. Bernstein raised shares of CVS Health from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $91.00 to $94.00 in a research note on Thursday, March 12th. TD Cowen reissued a “buy” rating on shares of CVS Health in a research note on Friday. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Finally, Leerink Partners reaffirmed an “outperform” rating and set a $98.00 price objective on shares of CVS Health in a research report on Thursday, March 5th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $95.05.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.